• Calendar
  • Contact
  • Equity Programs
  • Public Resources
  • Where to Buy
Cannabis Control Commission Massachusetts
  • Home
  • Patients and Caregivers
  • Applicants and Licensees
  • Adult Consumers
  • Parents
  • State and Local Government
  • Certifying Healthcare Providers
  • Search
  • Menu Menu

News / Bulletin | Federal Medical Cannabis Rescheduling and DEA Registration Information | November 18, 2026

Bulletin | Federal Medical Cannabis Rescheduling and DEA Registration Information | November 18, 2026

To: Marijuana Establishments and Medical Marijuana Establishments (Medical Marijuana Treatment Centers)
From: Travis Ahern, Executive Director
Date: November 18, 2026
Subject: Federal Medical Cannabis Rescheduling and DEA Registration Information

This bulletin is issued to Massachusetts licensed Marijuana Establishments and Medical Marijuana Establishments (Medical Marijuana Treatment Centers) (collectively, “licensees”).

The Cannabis Control Commission (Commission) continues to monitor recent federal developments regarding the treatment of medical cannabis under the federal Controlled Substances Act, including the U.S. Drug Enforcement Administration’s (DEA) implementation of a registration process for certain entities handling Schedule III medical cannabis.

Most recently, the DEA published information regarding certain entities that submitted applications for DEA registration to handle Schedule III medical cannabis. See information attached below. The Commission is sharing this information so that licensees have access to publicly available federal information.

The administration and enforcement of federal cannabis laws remain outside the Commission’s jurisdiction. The Commission has not received implementation guidance from any federal agencies regarding these developments and cannot provide guidance regarding DEA registration requirements or the interpretation or application of federal laws, regulations, or policies.

The Commission cannot provide legal, tax, or business advice regarding the impact of federal developments on individual licensees, registered entities, or other program participants. Businesses and individuals should consult their own attorneys, tax professionals, and other advisors regarding their specific circumstances.

The Commission will continue to administer and enforce Massachusetts cannabis laws and regulations, including G.L. c. 94G, G.L. c. 94I, and 935 CMR 500.000 and 501.000. Currently, these federal developments do not change the Commission’s administration of Massachusetts cannabis laws and regulations. Licensees remain responsible for complying with all applicable state requirements.

Resources

  • U.S. Drug Enforcement Administration (DEA) – Timely Applicant Information for Medical Marijuana Applicants
    https://www.deadiversion.usdoj.gov/drugreg/Timely-Applicant-Information-for-Medical-Marijuana-Applicants.pdf

Provided for informational purposes only.

Get Notified

Subscribe for updates from the Cannabis Control Commission.

Sign up for Updates
ccc logo
  • Home
  • Patients and Caregivers
  • Applicants and Licensees
  • Adult Consumers
  • Parents
  • State and Local Government
  • Certifying Healthcare Providers
  • Calendar
  • Contact
  • Equity Programs
  • Public Resources
  • Where to Buy
  • About
  • Announcements
  • Careers
  • FAQs
  • Investigations and Enforcement
  • News
  • Open Data
  • Press and Media
  • Public Health and Safety Advisories
  • Research

Affiliate Sites

  • MMJOS
  • MassCIP
  • Metrc
  • MoreAboutMJ.org
  • EquityWorks Career Hub
  • HelplineMA.org
Twitter Facebook LinkedIn YouTube
© Commonwealth of Massachusetts Cannabis Control Commission
WCVB | Cannabis commission greenlights drive-thru dispensaries in Massachus...
Scroll to top